Institutional Ownership Aurinia Pharmaceuticals Inc. (AUPH)
This table provides information about the institutional ownership of Aurinia Pharmaceuticals Inc. (AUPH). We have compiled data on the 227 institutions that hold shares in the stock, with a total of 58.9 Million shares, which have been reported (via 13F filing form) to have a value of $467 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,272,162
shares
|
$73.5 Million
0.0% of portfolio
|
Q2 2024
Added 7.03%
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
8,429,500
shares
|
$66.8 Million
5.69% of portfolio
|
Q4 2024
Added 16.6%
|
|
Armistice Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,400,000
shares
|
$50.8 Million
0.81% of portfolio
|
Q4 2024
Reduced 21.95%
|
|
Nea Management Company, LLC
Timonium, MD |
Feb 14, 2025 Q4 2024 |
3,969,834
shares
|
$31.5 Million
2.55% of portfolio
|
Q1 2022
Added 29.32%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,918,039
shares
|
$23.1 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.92%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,764,395
shares
|
$14 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.11%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,752,174
shares
|
$13.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 27.24%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,729,948
shares
|
$13.7 Million
0.0% of portfolio
|
Q4 2024
Added 6.93%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,645,129
shares
|
$13 Million
0.0% of portfolio
|
Q4 2024
Added 11.88%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,492,301
shares
|
$11.8 Million
0.0% of portfolio
|
Q4 2024
Added 10.19%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,075,911
shares
|
$8.53 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,054,365
shares
|
$8.36 Million
0.0% of portfolio
|
Q4 2024
Added 5.89%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
1,040,530
shares
|
$8.25 Million
2.74% of portfolio
|
Q3 2023
Added 81.43%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
927,298
shares
|
$7.35 Million
0.0% of portfolio
|
Q4 2024
Added 84.42%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
849,621
shares
|
$6.74 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
849,477
shares
|
$6.74 Million
0.06% of portfolio
|
Q4 2024
Added 69.73%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
700,900
shares
|
$5.56 Million
0.01% of portfolio
|
Q4 2024
Added 44.01%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
665,087
shares
|
$5.27 Million
0.0% of portfolio
|
Q4 2024
Reduced 10.61%
|
|
Citigroup Inc
|
Feb 12, 2025 Q4 2024 |
662,632
shares
|
$5.25 Million
0.0% of portfolio
|
Q4 2024
Added 1.29%
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
596,389
shares
|
$4.73 Million
0.01% of portfolio
|
Q4 2024
Added 341.9%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
556,454
shares
|
$4.41 Million
0.03% of portfolio
|
Q4 2024
Added 22.5%
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Feb 11, 2025 Q4 2024 |
516,877
shares
|
$4.1 Million
0.07% of portfolio
|
Q4 2024
Reduced 8.16%
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
463,163
shares
|
$3.67 Million
0.01% of portfolio
|
Q4 2024
Reduced 18.5%
|
|
Trexquant Investment LP
Stamford, CT |
Feb 12, 2025 Q4 2024 |
442,018
shares
|
$3.51 Million
0.05% of portfolio
|
Q4 2024
Reduced 24.19%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
363,674
shares
|
$2.88 Million
0.0% of portfolio
|
Q4 2024
Added 21.85%
|